top of page
Search Results

165 items found for "protease-activated receptors (PARs)"

  • Ep 70 with Dr. Stephen Ferguson

    Caron at Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor

  • Ep 69 with Dr. Stephen Ferguson

    Caron at Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor

  • Ep 78 with Dr. Stuart Maudsley

    Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor

  • Ep 37 with Dr. Samuel Hoare

    Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors life science, and academic scientists in the development of new therapeutics and the understanding of receptor about his love for GPCRs, kinetics, and decorticate the complexities of GPCR function to better target receptors

  • Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer

    signaling in cancer Published date April 25, 2023 Abstract " Activation of heterotrimeric G-proteins (Gαβγ) by G-protein-coupled receptors (GPCRs) is a quintessential mechanism of cell signaling widely However, it has become evident that heterotrimeric G-proteins can also be activated via GPCR-independent GIV/Girdin has emerged as a prototypical non-GPCR activator of G proteins that promotes cancer metastasis By revealing that small molecules can selectively disable noncanonical mechanisms of G-protein activation

  • Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology

    Sponsors GPCR Retreat Program < Back to schedule Pharmacological and Genetic Preclinical Models of Ghrelin Receptor dysregulation of metabolic function, particularly in response to obesogenic 'Western' diets (aka, ultra-processed

  • Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    research was focused on investigating the cellular effects of missense lung cancer-mutations in the G-protein-coupled receptor Autoproteolysis-Inducing (GAIN) domain of Latrophilin 3 receptor under the mentorship of Dr

  • Illuminating Functional Selectivity and Allosterism at GPCRs.

    pharmacology and his research program focuses on the molecular and cellular mechanisms regulating G protein-coupled receptor (GPCR) responses, a class of receptors involved in many, if not all, physiological responses He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor

  • Ep 152 with Dr Arthur Christopoulos

    Summary Arthur's Career Journey and Allosteric Receptors Yamina and Arthur discussed Arthur's career journey and his contributions to the field of pharmacology, with a focus on allosteric receptors and They also discussed their own research on chemokine receptors and the importance of understanding the his initial collaboration with Patrick Sexton on RAMPs and amylin receptors. They also delved into the different signaling of Class B receptors and the potential for modulation at

  • Ep 52 with Dr. Benjamin Myers

    His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors These studies have revealed new and unexpected ways for membrane lipids to regulate GPCR activity and

  • Noval insights and therapeutic strategies for tumor-induced kidney pathologies

    Xu et al. identified the mammalian neurokinin 3 receptor (TACR3), a homolog of the G protein-coupled receptor TkR99D in fruit flies, as a potential therapeutic target for alleviating renal tubular dysfunction

  • GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis

    Oncology and Immunology GPCR signaling contributes to immune characteristics of microenvironment and process disease model to study EBV-induced lymphomagenesis, incorporating genomic, transcriptomic, and in-depth proteomic Enhanced expression of chemokine receptor-1 (CCR1) on malignant and immunosuppressive cells modulated Therapeutic targeting CCR1 showed promising efficacy with EBV eradication, T-cell activation, and lymphoma and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 120 with Brendan Wilkins

    research assistant at the Victor Chang Cardiac Research Institute where he investigated the orphan G protein-coupled receptor (GPCR), GPR37L1. Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor

  • GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer

    GPCR News < GPCRs in Oncology and Immunology GPR176 Promotes Cancer Progression by Interacting with G Protein receptor superfamily, which responds to external stimuli and regulates cancer progression, but its role GPR176 is confirmed to activate the cAMP/PKA signaling pathway and modulate mitophagy, promoting CRC Mechanistically, the G protein GNAS is recruited intracellularly to transduce and amplify extracellular and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 88 with Dr. Hannes Schihada

    Hannes Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors

  • NPFF stimulates human ovarian cancer cell invasion by upregulating MMP-9 via ERK1/2 signaling

    NPFF regulates a variety of physiological functions by binding to a G protein-coupled receptor (GPCR) Our results also showed that ERK1/2 signaling was activated in SKOV3 cells in response to the NPFF treatment In addition, blocking the activation of ERK1/2 signaling abolished the NPFF-induced MMP-9 expression and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • GPCR Retreat 2023 | Dr. GPCR Ecosystem

    November 2-4, 2023 We are pleased to welcome you at Le Château Montebello , the 22nd Annual Great Lakes G Protein-Coupled Receptor Retreat held jointly with the Club des Récepteurs à Sept Domaines Transmembranaires du Québec University of North Carolina at Chapel Hill, unquestionably one of the pioneers involved in deciphering how receptor activity-modifying proteins or RAMPs regulate GPCR function, is confirmed as Plenary Speaker of the

  • CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitus

    Here, we demonstrate that CB2, a G-protein-coupled receptor (GPCR) and member of the endocannabinoid Our results show that CB2 stimulation of ILC2s protects against insulin-resistance onset, ameliorates Our mechanistic studies reveal that the therapeutic effects of CB2 are mediated through activation of and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Applying Pharmacology to Drug Discovery | Dr. GPCR Ecosystem

    This allows predictions of drug activity in all physiological systems, not only the system where testing Techniques will be described to quantify drug activity in terms of affinity, efficacy, and allosteric My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

  • Newsletter Sign Up | Dr. GPCR Ecosystem

    which we've curated the major advances in understanding GPCR biology and moving closer to targeting receptors

  • GPR4 in the pH-dependent migration of melanoma cells in the tumor microenvironment

    Membrane-bound receptors, such as the proton-sensitive GPCR (pH-GPCR) GPR4, are considered as potential GPR4 is involved in the migration of melanoma cells, especially in the tumor periphery, and that this process and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Session VIII * | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    coupled receptor 110 (ADGRF1, GPR110), an adhesion GPCR recently deorphanized, plays an important role (GAIN) domain of GPR110, and activates GPR110/cAMP signaling. This activation promotes neurogenic differentiation of neural stem cells, neurite growth, and synaptogenesis GPR110 is also highly expressed in the kidney, however, little is known about the function of this receptor The change in protein expression of key proteins including VEGFA is associated with the abnormal renal

  • A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages

    recruiting and regulating tumor-associated macrophages Published date May 28, 2023 Abstract "Adenosine 2a receptor highly expressed on LUAD cells promotes the secretion of chemokines and polarizing factors through activating and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency

    concentrations of adrenocorticotropic hormone and cortisol in plasma, as well as changes in sympathetic activity receptor (Gi-GPCR) neurons and neuropeptide changes. Progressive neuroinflammation spreads after injury, and neurotransmission through Gi-mediated G protein-coupled receptors in the HPA axis and neuropeptide production by the hypothalamus are inhibited. and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Explore / Individuals | Dr. GPCR Ecosystem

    Find out about your favorite receptor or company today! Job listings Are you looking to hire?

  • High Metabolite Concentrations in Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases

    Deficiency of SCFA would lead to pro-inflammatory immune cell skewing through insufficient G-protein coupled receptor (GPCR) signalling, or lack of histone deacetylase (HDAC) inhibition. and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling

    EVs express prosaposin, which binds to macrophage GPR37 to increase expression of the efferocytosis receptor and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 104 with Dr. Raul Gainetdinov

    Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification

bottom of page